Lumexa rises after Truist initiates with Buy
05/10/2026 13:12
BUZZ-Lumexa rises after Truist initiates with Buy ** Shares of diagnostics device provider Lumexa Imaging LMRI.O up 2% at $10.6 premarket
** Brokerage Truist Securities initiates coverage with a "Buy" rating and a PT of $18
** PT implies about 74% upside to the stock's last close
** Co provides diagnostic imaging services including MRI, CT and PET scans, as well as X-ray, ultrasound and mammography services
** LMRI carries a consensus "Buy" or higher rating from all 5 brokerages currently covering the stock; their median PT is $17.50 - LSEG-compiled data
** As of last close LMRI stock down 44.22% YTD
(Reporting by Darshan Kumar in Bengaluru)